SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-236266
Filing Date
2021-08-04
Accepted
2021-08-04 16:01:39
Documents
100
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d160269d6k.htm 6-K 11011
2 EX-99.1 d160269dex991.htm EX-99.1 91720
3 EX-99.2 d160269dex992.htm EX-99.2 594661
10 GRAPHIC g160269dsp111.jpg GRAPHIC 3146
11 GRAPHIC g160269g0722153033925.jpg GRAPHIC 4228
12 GRAPHIC g160269g0722153034490.jpg GRAPHIC 19931
13 GRAPHIC g160269g0803212105377.jpg GRAPHIC 4996
14 GRAPHIC g160269g0803212105550.jpg GRAPHIC 2881
  Complete submission text file 0001193125-21-236266.txt   6369134

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cyad-20210630.xml EX-101.INS 1688783
5 XBRL TAXONOMY EXTENSION SCHEMA cyad-20210630.xsd EX-101.SCH 93063
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cyad-20210630_cal.xml EX-101.CAL 48811
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cyad-20210630_def.xml EX-101.DEF 211156
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyad-20210630_lab.xml EX-101.LAB 461872
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyad-20210630_pre.xml EX-101.PRE 356407
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 211143890
SIC: 2834 Pharmaceutical Preparations